Audit 8284

FY End
2023-06-30
Total Expended
$124.30M
Findings
2
Programs
98
Year: 2023 Accepted: 2023-12-22
Auditor: Forvis LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
6384 2023-001 - - C
582826 2023-001 - - C

Programs

ALN Program Spent Major Findings
93.493 Congressional Directives $7.84M Yes 0
93.134 Grants to Increase Organ Donations $6.56M - 0
93.866 Aging Research $3.48M Yes 0
11.617 Congressionally-Identified Projects $3.23M Yes 1
93.859 Biomedical Research and Research Training $2.08M Yes 0
93.395 Cancer Treatment Research $1.89M Yes 0
93.393 Cancer Cause and Prevention Research $807,131 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $717,827 Yes 0
93.838 Lung Diseases Research $683,505 Yes 0
93.110 Maternal and Child Health Federal Consolidated Programs $651,275 - 0
93.361 Nursing Research $650,245 Yes 0
93.394 Cancer Detection and Diagnosis Research $633,018 Yes 0
93.077 Family Smoking Prevention and Tobacco Control Act Regulatory Research $611,247 Yes 0
93.351 Research Infrastructure Programs $600,000 Yes 0
93.600 Head Start $580,076 Yes 0
93.396 Cancer Biology Research $574,251 Yes 0
93.273 Alcohol Research Programs $514,746 Yes 0
93.279 Drug Abuse and Addiction Research Programs $494,494 Yes 0
93.247 Advanced Nursing Education Workforce Grant Program $487,905 - 0
93.242 Mental Health Research Grants $477,305 Yes 0
93.865 Child Health and Human Development Extramural Research $455,997 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $449,051 Yes 0
93.837 Cardiovascular Diseases Research $436,023 Yes 0
93.211 Telehealth Programs $435,788 - 0
93.575 Child Care and Development Block Grant $405,455 - 0
93.253 Poison Center Support and Enhancement Grant $400,524 - 0
93.658 Foster Care_title IV-E $379,499 - 0
93.839 Blood Diseases and Resources Research $363,800 Yes 0
93.558 Temporary Assistance for Needy Families $350,043 - 0
93.113 Environmental Health $341,097 Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $323,190 Yes 0
93.505 Covid-19 Affordable Care Act (aca) Maternal, Infant, and Early Childhood Home Visiting Program $319,689 - 0
93.855 Allergy, Immunology and Transplantation Research $309,726 Yes 0
93.RD Research and Development $246,390 Yes 0
93.350 National Center for Advancing Translational Sciences $243,766 Yes 0
93.433 Acl National Institute on Disability, Independent Living, and Rehabilitation Research $241,724 Yes 0
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement Program $237,112 - 0
93.600 Covid-19 Head Start $232,573 Yes 0
93.145 Hiv-Related Training and Technical Assistance $202,060 - 0
93.310 Trans-Nih Research Support $196,367 Yes 0
93.137 Community Programs to Improve Minority Health Grant Program $190,854 - 0
93.364 Nurse Student Loans $189,667 - 0
93.191 Graduate Psychology Education $162,464 - 0
93.500 Pregnancy Assistance Fund Program $144,590 - 0
93.307 Minority Health and Health Disparities Research $131,592 Yes 0
93.052 National Family Caregiver Support, Title Iii, Part E $128,491 - 0
10.331 Food Insecurity Nutrition Incentive Grants Program $127,444 - 0
12.750 Uniformed Services University Medical Research Projects $116,163 Yes 0
93.264 Nurse Faculty Loan Program (nflp) $113,789 - 0
93.879 Medical Library Assistance $109,294 Yes 0
12.420 Military Medical Research and Development $76,966 Yes 0
20.701 University Transportation Centers Program $73,780 Yes 0
47.041 Engineering $64,668 Yes 0
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation’s Health $58,724 - 0
93.397 Cancer Centers Support Grants $56,321 Yes 0
47.070 Computer and Information Science and Engineering $55,417 Yes 0
93.226 Research on Healthcare Costs, Quality and Outcomes $52,039 Yes 0
93.136 Injury Prevention and Control Research and State and Community Based Programs $50,460 - 0
93.173 Research Related to Deafness and Communication Disorders $48,818 Yes 0
93.603 Adoption and Legal Guardianship Incentive Payments $47,953 - 0
93.982 Mental Health Disaster Assistance and Emergency Mental Health $41,642 - 0
17.720 Disability Employment Policy Development $41,569 - 0
93.011 National Organizations of State and Local Officials $36,626 - 0
93.399 Cancer Control $34,987 Yes 0
93.434 Every Student Succeeds Act/preschool Development Grants $32,791 - 0
47.076 Education and Human Resources $32,169 Yes 0
93.877 Autism Collaboration, Accountability, Research, Education, and Support $30,962 Yes 0
93.470 Alzheimer's Disease Program Initiative (adpi) $29,996 - 0
93.262 Occupational Safety and Health Program $23,953 Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $23,328 Yes 0
93.969 Pphf Geriatric Education Centers $22,913 - 0
93.398 Cancer Research Manpower $22,156 Yes 0
93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders $21,555 Yes 0
43.007 Space Operations $17,051 Yes 0
93.884 Primary Care Training and Enhancement $16,135 - 0
93.121 Oral Diseases and Disorders Research $13,590 Yes 0
21.027 Covid-19 Coronavirus State and Local Fiscal Recovery Funds $10,089 - 0
93.268 Immunization Cooperative Agreements $9,507 - 0
10.250 Agricultural and Rural Economic Research, Cooperative Agreements and Collaborations $6,157 Yes 0
43.008 Office of Stem Engagement (ostem) $6,004 Yes 0
93.161 Health Program for Toxic Substances and Disease Registry $4,323 Yes 0
93.431 Networking2save: Cdc National Network Approach to Preventing and Controlling Tobacco-Related Cancers in Special Populations $3,206 - 0
94.003 Americorps State Commissions Support Grant $2,703 - 0
47.074 Biological Sciences $2,645 Yes 0
93.088 Advancing System Improvements for Key Issues in Women's Health $2,420 - 0
93.788 Opioid Str $1,810 - 0
93.365 Sickle Cell Treatment Demonstration Program $1,666 - 0
10.001 Agricultural Research_basic and Applied Research $997 - 0
64.RD Research and Development $942 Yes 0
93.103 Food and Drug Administration_research $609 Yes 0
93.172 Human Genome Research $455 Yes 0
16.560 National Institute of Justice Research, Evaluation, and Development Project Grants $-1 Yes 0
93.898 Cancer Prevention and Control Programs $-246 - 0
93.426 Improving the Health of Americans Through Prevention and Management of Diabetes and Heart Disease and Stroke $-647 - 0
93.632 University Centers for Excellence in Developmental Disabilities Education, Research, and Service $-2,546 - 0
93.243 Substance Abuse and Mental Health Services_projects of Regional and National Significance $-4,108 - 0
93.596 Child Care Mandatory and Matching Funds of the Child Care and Development Fund $-7,556 - 0
93.732 Mental and Behavioral Health Education and Training Grants $-88,178 - 0

Contacts

Name Title Type
YXJGGNC5J269 Mario Medina Auditee
9135586570 Allison Swaters Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: University of Kansas Medical Center Research Institute, Inc. has elected not to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards (the “Schedule”) includes the federal award activity of University of Kansas Medical Center Research Institute, Inc. (RI) under programs of the federal government for the year ended June 30, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of RI, it is not intended to and does not present the financial position, changes in net assets or cash flows of RI.
Title: Summary of Significant Accounting Policies Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: University of Kansas Medical Center Research Institute, Inc. has elected not to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years.
Title: Indirect Cost Rate Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: University of Kansas Medical Center Research Institute, Inc. has elected not to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance. University of Kansas Medical Center Research Institute, Inc. has elected not to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance.

Finding Details

U.S. Department of Commerce Congressionally Identified Projects – 11.617 Award Number - 60NANB22D201 Criteria or Specific Requirement – Cash Management 2 CFR 200.305(b) of the compliance supplement requires organizations receiving federal funds to establish controls and procedures that would minimize the amount of time between drawdowns and disbursement of the funds. As required per the Department of Commerce Financial Assistance Standard Terms and Conditions, Section B, "Financial Requirements", paragraph .02.b1, advanced payments must be limited to immediate cash needs and must time advance payment requests so that Federal funds are on hand for a maximum of 30 calendar days before being disbursed by the non-Federal entity for allowable award costs. Condition – RI requested an advance payment in October 2022 for anticipated expenditures and did not expend all funding within the 30 day period. Questioned Costs – None noted. Context – We selected one drawdown for $1,000,000 out of three drawdowns totaling $3,000,000 during fiscal year 2023 for testing. During our testwork, we noted that a portion of the drawdown was not expended within the 30 day period following the receipt of the drawdown. The sample was not intended to be, and was not a statistically valid sample. Effect – RI did not comply with the 30 day period required for advanced payments. Cause – RI had issued purchase orders to vendors prior to advance payment request, but did not receive invoices from vendors for payment within the 30 day period and, as such, did not disburse funding. Identification as a Repeat Finding – Not applicable. Recommendation – We recommend RI only request advance payments up to the amount they are able to disburse within the required time in order to minimize the time elapsing between the receipt and disbursement of federal funds. Views of Responsible Officials and Planned Corrective Actions – Management agrees with the stated finding and has implemented a corrective action plan.
U.S. Department of Commerce Congressionally Identified Projects – 11.617 Award Number - 60NANB22D201 Criteria or Specific Requirement – Cash Management 2 CFR 200.305(b) of the compliance supplement requires organizations receiving federal funds to establish controls and procedures that would minimize the amount of time between drawdowns and disbursement of the funds. As required per the Department of Commerce Financial Assistance Standard Terms and Conditions, Section B, "Financial Requirements", paragraph .02.b1, advanced payments must be limited to immediate cash needs and must time advance payment requests so that Federal funds are on hand for a maximum of 30 calendar days before being disbursed by the non-Federal entity for allowable award costs. Condition – RI requested an advance payment in October 2022 for anticipated expenditures and did not expend all funding within the 30 day period. Questioned Costs – None noted. Context – We selected one drawdown for $1,000,000 out of three drawdowns totaling $3,000,000 during fiscal year 2023 for testing. During our testwork, we noted that a portion of the drawdown was not expended within the 30 day period following the receipt of the drawdown. The sample was not intended to be, and was not a statistically valid sample. Effect – RI did not comply with the 30 day period required for advanced payments. Cause – RI had issued purchase orders to vendors prior to advance payment request, but did not receive invoices from vendors for payment within the 30 day period and, as such, did not disburse funding. Identification as a Repeat Finding – Not applicable. Recommendation – We recommend RI only request advance payments up to the amount they are able to disburse within the required time in order to minimize the time elapsing between the receipt and disbursement of federal funds. Views of Responsible Officials and Planned Corrective Actions – Management agrees with the stated finding and has implemented a corrective action plan.